Stocks trading at 20 times sales or more, including Lumentum, Nebius, AMD, Palantir, AppLovin and Strategy, are at risk going into 2027. Only 13 Nasdaq companies remain at that level, and far more sit in the Russell 2000, where AI high flyers hide among biotech names. x.comÂ








